581 related articles for article (PubMed ID: 19227010)
21. Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation.
Zahner G; Schaper M; Panzer U; Kluger M; Stahl RA; Thaiss F; Schneider A
Biochem J; 2009 Aug; 422(3):563-70. PubMed ID: 19570035
[TBL] [Abstract][Full Text] [Related]
22. [Prostaglandin E2 promotes hepatocellular carcinoma cell proliferation through EP2 prostanoid receptor].
Guo D; Chen NN; Hou LB; Lei LS
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1564-7. PubMed ID: 21945767
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors.
Wang XS; Lau HY
Allergy; 2006 Apr; 61(4):503-6. PubMed ID: 16512814
[TBL] [Abstract][Full Text] [Related]
24. Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells.
Wise H
Eur J Pharmacol; 2006 Mar; 535(1-3):69-77. PubMed ID: 16545798
[TBL] [Abstract][Full Text] [Related]
25. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
[TBL] [Abstract][Full Text] [Related]
26. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of lymphocytic cholinergic activity by ONO-4819, a selective prostaglandin EP4 receptor agonist, in MOLT-3 human leukemic T cells.
Suenaga A; Fujii T; Ogawa H; Maruyama T; Ohuchida S; Katsube N; Obata T; Kawashima K
Vascul Pharmacol; 2004 Mar; 41(2):51-8. PubMed ID: 15196475
[TBL] [Abstract][Full Text] [Related]
28. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol.
Hardwick M; Fertikh D; Culty M; Li H; Vidic B; Papadopoulos V
Cancer Res; 1999 Feb; 59(4):831-42. PubMed ID: 10029072
[TBL] [Abstract][Full Text] [Related]
29. Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells.
Wang LS; Huang YW; Liu S; Chang HL; Ye W; Shu S; Sugimoto Y; Funk JA; Smeaks DD; Hill LN; Lin YC
Anticancer Res; 2006; 26(2A):889-98. PubMed ID: 16619484
[TBL] [Abstract][Full Text] [Related]
30. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus.
Piazuelo E; Jiménez P; Strunk M; Santander S; García A; Esteva F; Lanas A
Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):150-61. PubMed ID: 17085323
[TBL] [Abstract][Full Text] [Related]
31. Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model.
Parida S; Parekh A; Dey G; Ghosh SC; Mandal M
Cancer Biol Ther; 2015; 16(6):922-32. PubMed ID: 25894216
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors.
Hatazawa R; Tanaka A; Tanigami M; Amagase K; Kato S; Ashida Y; Takeuchi K
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G788-97. PubMed ID: 17673547
[TBL] [Abstract][Full Text] [Related]
33. The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines.
Gilhooly EM; Rose DP
Int J Oncol; 1999 Aug; 15(2):267-70. PubMed ID: 10402236
[TBL] [Abstract][Full Text] [Related]
34. A molecular role for lysyl oxidase in breast cancer invasion.
Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ
Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058
[TBL] [Abstract][Full Text] [Related]
35. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells.
Basu GD; Liang WS; Stephan DA; Wegener LT; Conley CR; Pockaj BA; Mukherjee P
Breast Cancer Res; 2006; 8(6):R69. PubMed ID: 17156488
[TBL] [Abstract][Full Text] [Related]
36. Decidualization and maintenance of a functional prostaglandin system in human endometrial cell lines following transformation with SV40 large T antigen.
Chapdelaine P; Kang J; Boucher-Kovalik S; Caron N; Tremblay JP; Fortier MA
Mol Hum Reprod; 2006 May; 12(5):309-19. PubMed ID: 16556676
[TBL] [Abstract][Full Text] [Related]
37. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.
Chen MJ; Chiou PP; Lin P; Lin CM; Siri S; Peck K; Chen TT
J Cell Biochem; 2007 Aug; 101(5):1316-27. PubMed ID: 17286280
[TBL] [Abstract][Full Text] [Related]
38. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E2 inhibits advanced glycation end product-induced adhesion molecule expression on monocytes, cytokine production, and lymphocyte proliferation during human mixed lymphocyte reaction.
Takahashi HK; Zhang J; Mori S; Liu K; Wake H; Liu R; Sadamori H; Matsuda H; Yagi T; Yoshino T; Nishibori M
J Pharmacol Exp Ther; 2010 Sep; 334(3):964-72. PubMed ID: 20558773
[TBL] [Abstract][Full Text] [Related]
40. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.
Carrasco E; Casper D; Werner P
J Neurosci Res; 2007 Nov; 85(14):3109-17. PubMed ID: 17868147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
